Skip to content
Review

Targeting kinases in neurodegenerative diseases and cancer: Structural insights and therapeutic strategies.

2026 · Advances in Protein Chemistry and Structural Biology · Vol 153, pp. 95-134 · 0 citations
Medicine

TL;DR

This chapter summarizes the recent progress that places kinases in a context-dependent state of molecular switches with disease-specific outcomes determined by structural conformation, spatiotemporal regulation, and network integration as opposed to kinase identity and describes the efficacy and drawbacks of first-generation ATP-competitive inhibitors.

View source

Similar papers

Review Open access Sep 2026

Targeting MAPK9 in neurodegenerative diseases: mechanistic insights, phytochemical modulators, and emerging computational approaches

The protein Mitogen-activated protein kinase 9 (MAPK9) (c-Jun N-terminal kinase 2 [JNK2]) is a critical signalling molecule involved in cellular survival, inflammation, oxidative stress, and the programming of cell death. This is because there has been emerging evidence of the effects of the abnormal activation of MAPK...

S. Otun, I. Achilonu · 0 citations
Review Open access Aug 2026

Cell Death in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets

This review examines RCD as an integrated pathogenic network in major NDs as well as evaluating emerging therapeutic strategies that target cell death crosstalk, restore autophagy lysosomal competence, or improve delivery to the central nervous system.

Tianjiao Li, Qian Zhang, Yichen Wu et al. · 0 citations
Review Open access Sep 2026

Cancer degronopathies and protein-fate biomarkers in drug resistance and cancer progression: signalling mechanisms, measurement and translational limits

Drug resistance remains a major barrier to durable targeted therapy, and cancer progression often reflects rewiring of signalling pathways that control protein stability. Dysregulation of the ubiquitin–proteasome system, including failure of degron-dependent substrate recognition, can stabilise oncogenic proteins, acce...

Jia-Xin Li, Shu-Han Liu, Lu Fu et al. · 0 citations
Review Open access Oct 2026

Fyn kinase: a key mechanistic regulator and therapeutic target in tauopathy and neurodegenerative diseases

Synaptic dysfunction and intracellular accumulation of pathological tau are convergent hallmarks of Alzheimer’s disease (AD) and related tauopathies, yet the molecular mechanisms coupling these events to widespread neurodegeneration remain incompletely understood. The Src family kinase Fyn has emerged as a critical sig...

Hai-Wen Wang, Xing Fan, Jian-Chao Ping et al. · 0 citations

Targeting Aberrant Protein-Protein Interactions in Cancer and Neurodegenerative Diseases

Protein-protein interactions (PPIs) are critical for the physiological growth, development, and maintenance of all cells throughout the human body. However, genetic mutations, aging, and environmental exposures can lead to the induction of aberrant PPIs (aPPIs), which have been implicated in various ailments, including...

Tyler D. Ball · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.